In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...

Advances in analytical chemistry are improving food safety. From mass spectrometry to machine learning and biosensors, ...

A new deep-learning model improved surgeons’ recognition of pelvic anatomy in video-based PLND tests, though live surgical validation is still needed.

In a significant breakthrough for cancer diagnostics, Reliance Industries subsidiary Strand Life Sciences has secured an Indian patent for an artificial intelligence-powered technology that can detect ...

Revolutionizing billing infrastructure for automatedVAT refund processing and tax reclaims, with over 200,000 bills already scanned and recorded on Hedera within two weeks of go-live.

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

Reliance's Strand Life Sciences patents a liquid biopsy platform for early cancer detection using AI and cfDNA analysis in ...

New research from global AI-first cloud communications platform Infobip reveals a growing surge in AI-powered fraud and enterprise defenses.

Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...